561 filings
Page 9 of 29
8-K
MBRX
Moleculin Biotech Inc
4 May 22
Moleculin Engages Wolfram C. M. Dempke, MD, PhD, MBA as its European Chief Medical Officer
8:15am
8-K
MBRX
Moleculin Biotech Inc
21 Apr 22
Moleculin Receives IND Clearance to Conduct Phase 1 Study of WP1066 for the Treatment of Recurrent Malignant Glioma
8:45am
DEF 14A
MBRX
Moleculin Biotech Inc
Definitive proxy
14 Apr 22
5:01pm
8-K/A
MBRX
Moleculin Biotech Inc
12 Apr 22
Moleculin Announces Presentation of Positive Preclinical Annamycin Data at the AACR 2022 Annual Meeting
8:57am
8-K
MBRX
Moleculin Biotech Inc
8 Apr 22
Moleculin Announces Presentation of Positive Preclinical Annamycin Data at the AACR 2022 Annual Meeting
4:32pm
PRE 14A
MBRX
Moleculin Biotech Inc
Preliminary proxy
4 Apr 22
5:17pm
8-K
MBRX
Moleculin Biotech Inc
25 Mar 22
Moleculin Reports Full Year Financial Results and Provides Programs Update
7:05am
10-K
2021 FY
MBRX
Moleculin Biotech Inc
Annual report
24 Mar 22
4:37pm
4
Joy Yan
2 Mar 22
Moleculin Biotech / Joy Yan ownership change
9:48pm
3
MBRX
Moleculin Biotech Inc
2 Mar 22
Moleculin Biotech / Joy Yan ownership change
9:47pm
8-K
MBRX
Moleculin Biotech Inc
1 Mar 22
Moleculin Announces Appointment of Joy Yan, M.D., Ph.D. to Board of Directors
8:35am
8-K
MBRX
Moleculin Biotech Inc
15 Feb 22
Regulation FD Disclosure
4:35pm
8-K
MBRX
Moleculin Biotech Inc
14 Feb 22
Moleculin Provides Annamycin AML Program Update and Outlines Next Steps to Advance Towards Late-Stage Development
9:00am
8-K
MBRX
Moleculin Biotech Inc
18 Jan 22
Regulation FD Disclosure
8:30am
8-K
MBRX
Moleculin Biotech Inc
10 Jan 22
Regulation FD Disclosure
7:00am
8-K
MBRX
Moleculin Biotech Inc
27 Dec 21
Entry into a Material Definitive Agreement
8:06am
8-K
MBRX
Moleculin Biotech Inc
17 Dec 21
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
MBRX
Moleculin Biotech Inc
1 Dec 21
Regulation FD Disclosure
8:30am
8-K
MBRX
Moleculin Biotech Inc
12 Nov 21
Moleculin Reports Third Quarter 2021 Financial Results and Provides Programs Update
7:30am
10-Q
2021 Q3
MBRX
Moleculin Biotech Inc
Quarterly report
10 Nov 21
4:15pm